Recall Issued on Naturalyte and GranuFlo Dialysis Products

Share Article

Ennis & Ennis, P.A. Announces Free Nationwide Consultations for Patients Affected by Fresenius' Naturalyte and GranuFlo Recall

On June 27, 2012, the FDA issued a recall for Fresenius Medical Care North America's dialysis products, Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate, due to a risk of potentially fatal serum bicarbonate levels. Naturalyte Liquid and Naturalyte GranuFlo are dialysis products.

On November 4, 2011, Fresenius sent an internal memo to doctors in the company’s dialysis centers informing of the risk and noted that 941 hemodialysis patients using the company’s products experienced cardiac arrest in 2010. However, Fresenius failed to inform the FDA and other facilities that used the product. It wasn’t until March 2012, when the FDA received an anonymous copy of the November internal memo, that other facilities became aware of this fatal danger.

If you have a loved one who suffered a cardiovascular event while or shortly after receiving dialysis with Naturalyte Liquid or Naturalyte GranuFlo products, contact the lawyers of Ennis & Ennis, P.A. today for a free nationwide confidential consultation by calling toll free 1-800-856-6405 or by completing an online case evaluation form.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.

Ennis & Ennis, P.A. is also investigating cases involving Accutane, Actos, Avandia, Fosamax, Pradaxa, Plavix, Paxil/Birth Defect, Zoloft/Birth Defect, Prozac/Birth Defect, Depuy Hip Recall, Zimmer Hip Recall, Wright Conserve Hip, Wright Profemur Hip, all Metal-on-Metal Hips, Medtronic Infuse Bone Graft, Tekturna, Reglan, Yaz, Yasmin and Ocella Birth Control Pills.

Remember the law limits the time in which a claim can be filed, so don't wait to explore your legal rights.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Attorney David Ennis
Visit website